Arcosa Future Growth
Future criteria checks 4/6
Arcosa is forecast to grow earnings and revenue by 35.4% and 11.1% per annum respectively. EPS is expected to grow by 35.5% per annum. Return on equity is forecast to be 8.7% in 3 years.
Key information
35.4%
Earnings growth rate
35.5%
EPS growth rate
Construction earnings growth | 27.4% |
Revenue growth rate | 11.1% |
Future return on equity | 8.7% |
Analyst coverage | Low |
Last updated | 13 Dec 2024 |
Recent future growth updates
Earnings Beat: Arcosa, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 06Arcosa, Inc. Just Recorded A 58% EPS Beat: Here's What Analysts Are Forecasting Next
May 05Recent updates
The Price Is Right For Arcosa, Inc. (NYSE:ACA)
Oct 24Arcosa: Still Not Cheap Enough
Oct 23Calculating The Fair Value Of Arcosa, Inc. (NYSE:ACA)
Oct 06Arcosa (NYSE:ACA) Seems To Use Debt Quite Sensibly
Sep 17Arcosa: Acquisition Of Stavola Is Expected To Strengthen Its Construction Products Segment
Aug 09Earnings Beat: Arcosa, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 06Arcosa, Inc.'s (NYSE:ACA) Share Price Matching Investor Opinion
Jul 16A Look At The Intrinsic Value Of Arcosa, Inc. (NYSE:ACA)
Jun 27Arcosa: Robust Infrastructure Spending And Electric Utility Transmission CAPEX
Jun 15Is Arcosa (NYSE:ACA) A Risky Investment?
Jun 09Arcosa, Inc. Just Recorded A 58% EPS Beat: Here's What Analysts Are Forecasting Next
May 05Shareholders Will Probably Not Have Any Issues With Arcosa, Inc.'s (NYSE:ACA) CEO Compensation
May 03Arcosa: Infrastructure Play Looking Sound
Apr 11What Arcosa, Inc.'s (NYSE:ACA) P/E Is Not Telling You
Apr 06Estimating The Fair Value Of Arcosa, Inc. (NYSE:ACA)
Feb 19Arcosa: A Good Business But Already Priced In
Feb 09Does Arcosa (NYSE:ACA) Have A Healthy Balance Sheet?
Feb 02Does Arcosa (NYSE:ACA) Deserve A Spot On Your Watchlist?
Jan 18Benign Growth For Arcosa, Inc. (NYSE:ACA) Underpins Its Share Price
Jan 03Arcosa: Government Spending Is A Tailwind But Valuation Is High
Nov 03Arcosa: Some Warning Signs
Aug 10Arcosa Non-GAAP EPS of $0.24 beats by $0.04, revenue of $500.3M beats by $23.65M
Feb 23Arcosa Q4 2022 Earnings Preview: Opinion Unchanged
Feb 17Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3,178 | 265 | 172 | 418 | 4 |
12/31/2025 | 2,958 | 219 | 215 | 384 | 5 |
12/31/2024 | 2,594 | 131 | 94 | 298 | 5 |
9/30/2024 | 2,486 | 128 | 121 | 316 | N/A |
6/30/2024 | 2,437 | 147 | 16 | 225 | N/A |
3/31/2024 | 2,357 | 142 | 101 | 314 | N/A |
12/31/2023 | 2,308 | 159 | 58 | 261 | N/A |
9/30/2023 | 2,226 | 286 | -6 | 191 | N/A |
6/30/2023 | 2,238 | 282 | 36 | 218 | N/A |
3/31/2023 | 2,256 | 280 | 21 | 177 | N/A |
12/31/2022 | 2,243 | 245 | 36 | 174 | N/A |
9/30/2022 | 2,264 | 100 | 162 | 272 | N/A |
6/30/2022 | 2,220 | 91 | 130 | 227 | N/A |
3/31/2022 | 2,132 | 74 | 100 | 191 | N/A |
12/31/2021 | 2,036 | 69 | 81 | 167 | N/A |
9/30/2021 | 1,974 | 70 | 24 | 110 | N/A |
6/30/2021 | 1,904 | 78 | 111 | 191 | N/A |
3/31/2021 | 1,888 | 90 | 138 | 219 | N/A |
12/31/2020 | 1,936 | 106 | 178 | 260 | N/A |
9/30/2020 | 1,924 | 116 | 285 | 367 | N/A |
6/30/2020 | 1,879 | 118 | 248 | 338 | N/A |
3/31/2020 | 1,814 | 116 | 187 | 275 | N/A |
12/31/2019 | 1,737 | 112 | 273 | 359 | N/A |
9/30/2019 | 1,664 | 119 | 146 | 219 | N/A |
6/30/2019 | 1,598 | 90 | 91 | 154 | N/A |
3/31/2019 | 1,517 | 81 | 99 | 154 | N/A |
12/31/2018 | 1,460 | 76 | 74 | 119 | N/A |
9/30/2018 | 1,434 | 72 | 77 | 146 | N/A |
6/30/2018 | 1,421 | 89 | N/A | 174 | N/A |
3/31/2018 | 1,421 | 88 | N/A | 187 | N/A |
12/31/2017 | 1,462 | 90 | N/A | 162 | N/A |
12/31/2016 | 1,704 | 123 | N/A | 228 | N/A |
12/31/2015 | 2,140 | 135 | N/A | 293 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACA's forecast earnings growth (35.4% per year) is above the savings rate (2.6%).
Earnings vs Market: ACA's earnings (35.4% per year) are forecast to grow faster than the US market (15.2% per year).
High Growth Earnings: ACA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ACA's revenue (11.1% per year) is forecast to grow faster than the US market (9.1% per year).
High Growth Revenue: ACA's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ACA's Return on Equity is forecast to be low in 3 years time (8.7%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 05:39 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Arcosa, Inc. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Adam Seiden | Barclays |
Daniel Wang | Berenberg |
Robert Labick | CJS Securities, Inc. |